Corticosteroids in Duchenne muscular dystrophy: impact on the motor function measure sensitivity to change and implications for clinical trials
- 9 October 2017
- journal article
- research article
- Published by Wiley in Developmental Medicine & Child Neurology
- Vol. 60 (2) , 185-191
Abstract
Aim: To monitor the evolution of the motor function of ambulatory patients with Duchenne muscular dystrophy ( DMD ) treated by corticosteroids for 2 years in comparison with untreated patients. Method: This observational, multicentre cohort study explores the evolution of the motor function measure ( MFM ) over a 24‐month period for 29 ambulant corticosteroids‐treated and 45 ambulant untreated patients with DMD. Results: Significant differences were found between mean MFM scores in corticosteroids‐treated and untreated groups for domain 1 of the MFM (standing position and transfers; D1), domain 2 of the MFM (axial and proximal motor function; D2), and domain 3 of the MFM (distal motor function; D3). Subscores were between 0 months and 6 months, and 0 months and 24 months. For the D1 subscore specifically, there was a significant increase in the corticosteroids‐treated group (mean±standard deviation [ SD ] slope of change=12.6±15.5%/y), while a decrease was observed in the untreated group (−17.8±17.7%/y) between 0 months and 6 months ( p <0.001). Sensitivity to change as assessed by standardized response means was high between 12 months and 24 months for D1 of both corticosteroids‐treated and untreated groups (1.0 and 1.2 respectively), and low for D2 and D3 of both treated and untreated groups. Interpretation: Patients with DMD treated by corticosteroids present a different course of the disease as assessed by MFM , confirming the sensitivity to change of the MFM in this population. What this paper adds: Corticosteroids have a quantitative impact on muscle strength 6 to 24 months after starting treatment. Motor function measure is a valid outcome measure in Duchenne muscular dystrophy patients under corticosteroid treatment.Keywords
This publication has 22 references indexed in Scilit:
- Motor assessment in patients with Duchenne muscular dystrophyArquivos de Neuro-Psiquiatria, 2012
- Upper limb function in adults with Duchenne muscular dystrophyJournal of Rehabilitation Medicine, 2011
- North Star Ambulatory Assessment, 6-minute walk test and timed items in ambulant boys with Duchenne muscular dystrophyNeuromuscular Disorders, 2010
- Change in Natural History of Duchenne Muscular Dystrophy With Long-term Corticosteroid Treatment: Implications for ManagementJournal of Child Neurology, 2010
- Monitoring changes and predicting loss of ambulation in Duchenne muscular dystrophy with the Motor Function MeasureDevelopmental Medicine & Child Neurology, 2009
- The 6‐minute walk test as a new outcome measure in Duchenne muscular dystrophyMuscle & Nerve, 2009
- Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decadeNeuromuscular Disorders, 2006
- A motor function measure scale for neuromuscular diseases. Construction and validation studyNeuromuscular Disorders, 2005
- Practice Parameter: Corticosteroid treatment of Duchenne dystrophy [RETIRED]Neurology, 2005
- Analysing changes in the presence of informative right censoring caused by death and withdrawalStatistics in Medicine, 1988